Finally, as ACLY is also overexpressed in a wide variety of tumors, such as hepatocellular carcinoma [2], it is reasonable to suppose that liposomal HCA might be useful for the treatment of cancer, maybe in combination with other drugs. Here, ACLY is linked to hepatocellular carcinoma.